CareDx Inc (CDNA) Shares Fall 4.0% -- GF Value Says Still Overvalued

gurufocus.com · 2026-10-17

On October 16, 2026, CareDx Inc (CDNA) shares fell 4.0% to $64.00, reflecting a volatile performance over the past year, with a 52-week high of $72.51 and a low

TickrTrends take: CareDx shares declined 4 percent following a reaffirmation of its overvalued status according to GuruFocus valuation metrics, yet TickrTrends maintains the same overvalued assessment despite the stock movement. For investors focused on valuation in the Healthcare sector, the persistence of an overvalued rating even after a price decline suggests the company's valuation multiples may remain elevated relative to fundamental metrics. Observers tracking CDNA should monitor whether further price adjustments occur or if the gap between market valuation and intrinsic value estimates continues to warrant caution.

Read the full story at gurufocus.com →